Similar Search Results

Pharmaceutical Innovation, Mortality Reduction, and Economic Growth

Lichtenberg, Frank - National Bureau of Economic Research (NBER) - 1998

We perform an econometric investigation of the contribution of pharmaceutical innovation to mortality reduction and … pharmaceutical innovation, there would have been no increase and perhaps even a small decrease in mean age at death, and that new … drugs have increased life expectancy, and lifetime income, by about 0.75-1.0% per annum. The drug innovation measures are …

Persistent link: https://www.econbiz.de/10005778568

Technology, Trade, and Wages

Adams, James - National Bureau of Economic Research (NBER) - 1997

same, not oppo- site effect on wages at both skill levels; a rise in the foreign share in world innovation or US patents … decreases US wages; an increase in the US share in world innovation or US patents raises US wages, especially for the less … skilled; and the stock of world innovation and US patents decreases real wages especially for the less skilled. Turning to the …

Persistent link: https://www.econbiz.de/10005710318

The Growing Allocative Inefficiency of the U.S. Higher Education Sector

Adams, James; Clemmons, J. Roger - National Bureau of Economic Research (NBER) - 2006

This paper presents new evidence on research and teaching productivity in universities using a panel of 102 top U.S. schools during 1981-1999. Faculty employment grows at 0.6 percent per year, compared with growth of 4.9 percent in industrial researchers. Productivity growth per researcher is...

Persistent link: https://www.econbiz.de/10005710600

The Effect of New Drugs on Mortality from Rare Diseases and HIV

Lichtenberg, Frank - National Bureau of Economic Research (NBER) - 2001

I investigate the effect of large increases in the number of drugs available to treat rare diseases and HIV on mortality associated with them. Mortality from both diseases declined dramatically following increases in drug approvals. Before the Orphan Drug Act went into effect (between 1979 and...

Persistent link: https://www.econbiz.de/10005720742

Sources of U.S. Longevity Increase, 1960-1997

Lichtenberg, Frank - National Bureau of Economic Research (NBER) - 2002

models using annual U.S. time-series data on life expectancy, health expenditure, and medical innovation. Reliable annual … data are available for only one type of innovation - new drugs - but pharmaceutical R&D accounts for a significant fraction … innovation (in the form of new drug approvals) and expenditure on medical care (especially public expenditure) contributed to …

Persistent link: https://www.econbiz.de/10005828594

The Output Contributions of Computer Equipment and Personnel: A Firm- Level Analysis

Lichtenberg, Frank - National Bureau of Economic Research (NBER) - 1993

This paper examines the output contributions of capital and labor deployed in information systems (IS) at the firm level during the period 1988-91 throughout the business sector, using two different sources of data on these inputs. Our production function estimates suggest that there are...

Persistent link: https://www.econbiz.de/10005828845

The Effect of Changes in Drug Utilization on Labor Supply and Per Capita Output

Lichtenberg, Frank - National Bureau of Economic Research (NBER) - 2002

We hypothesize that pharmaceutical-embodied technical progress increases per capita output via its effect on labor supply (the employment rate and hours worked per employed person). We examine the effect of changes in both the average quantity and average vintage (FDA approval year) of drugs...

Persistent link: https://www.econbiz.de/10005775072

Science and Industry: Tracing the Flow of Basic Research through Manufacturing and Trade

Adams, James; Clemmons, Roger - National Bureau of Economic Research (NBER) - 2006

This paper describes flows of basic research through the U.S. economy and explores their implications for scientific output at the industry and field level. The time period is the late 20th century. This paper differs from others in its use of measures of science rather than technology. Together...

Persistent link: https://www.econbiz.de/10005088639

Scientific Teams and Institution Collaborations: Evidence from U.S. Universities, 1981-1999

Adams, James - National Bureau of Economic Research (NBER) - 2004

This paper explores recent trends in the size of scientific teams and in institutional collaborations. The data derive from 2.4 million scientific papers written in 110 leading U.S. research universities over the period 1981-1999. We measure team size by the number of authors on a scientific...

Persistent link: https://www.econbiz.de/10005050357

The NBER-Rensselaer Scientific Papers Database: Form, Nature, and Function

Adams, James; Clemmons, J. Roger - National Bureau of Economic Research (NBER) - 2008

This article is a guide to the NBER-Rensselaer Scientific Papers Database, which includes more than 2.5 million scientific publications and over 21 million citations to those papers. The data cover an important sample of 110 top U.S. universities and 200 top U.S.-based R&D-performing firms...

Persistent link: https://www.econbiz.de/10005575301